Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 699 21 829.2 |
96 | EP file number | EAKZ | 99 94 3712.2 |
86 | WO file number | WAKZ | PCT/US99/18584 |
97 | EP publication number | EPN | 1104415 |
87 | WO publication number | WPN | 2000009494 |
54 | Designation/title | TI | VERFAHREN ZUR HERSTELLUNG VON 1,3-OXATHIOLANNUKLEOSIDE |
51 | IPC main class | ICM (ICMV) | C07D 327/04 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07D 411/04 (2006.01), C07D 473/00 (2006.01), A61K 31/505 (2006.01) |
22 | DE application date | DAT | Aug 12, 1999 |
96 | EP application date | EAT | Aug 12, 1999 |
86 | WO application date | WAT | Aug 12, 1999 |
43 | Date of first publication | OT | Feb 24, 2000 |
| Date of publication of grant | PET | Nov 10, 2004 |
71/73 | Applicant/owner | INH | Gilead Sciences, Inc., 94404 Foster City, Calif., US; Emory University, Atlanta, Ga., US |
72 | Inventor | IN | PAINTER R., George, Chapel Hill, US; LIOTTA C., Dennis, McDonough, US; ALMOND, Merrick, Apex, US; CLEARY, Darryl, Chapel Hill, US; SORIA, Jose, Decatur, US; SZNAIDMAN, Marcos Luis, Durham, US |
74 | Representative | VTR | Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE |
10 | Published DE documents | DEPN | Original document:
DE000069921829T2 Searchable text:
DE000069921829T2 |
| Address for service | | Müller-Boré & Partner Patentanwälte PartG mbB, 80639 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 96214 P Aug 12, 1998
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 122841 P Mar 4, 1999
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
87 | WO language of publication | WLANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE |
81 | Designated WO countries | WDS | RO |
| Published EP/WO documents | EPWOPN | Original document:
EP000001104415 Searchable text:
EP000001104415 Original document:
EP000001104415B1 Searchable text:
EP000001104415B1 Original document:
WO002000009494 Searchable text:
WO002000009494 |
43 | Date of first publication | EVT | Feb 24, 2000 |
| Date of the first transfer into DPMAregister | EREGT | Sep 29, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 5, 2025 (Show all update days)(Hide all update days)- Jan 5, 2025
- St.36: changed (technical change)
- Aug 14, 2019; Oct 25, 2018; Sep 8, 2018; Aug 17, 2017; Feb 28, 2017; Aug 23, 2016; Sep 9, 2015; Sep 5, 2015; Aug 25, 2015; Aug 14, 2015; Aug 20, 2014; Sep 11, 2013; Aug 16, 2013; Jan 23, 2013
- Historical data not available for this/these date(s)
- Sep 29, 2012
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 5)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Oct 7, 2004 |
71/73 | Applicant/owner | INH | Gilead Sciences, Inc., 94404 Foster City, Calif., US; Emory University, Atlanta, Ga., US |
71/73 | Previous applicant/owner | INHF | Painter, George R., Chapel Hill, N.C., US, Almond, Merrick, Apex, N.C., US, Cleary, Darry, Chapel Hill, N.C., US, Soria, Jose, Decatur, Ga., US, Sznaidman, Marcos Luis, Durham, N.C., US, Triangle Pharmaceuticals Inc., Durham, N.C., US, Emory University, Atlanta, Ga., US, Liotta, Dennis C., McDonough, Ga., US |